Paroxetine and pindolol: A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency

International Clinical Psychopharmacology

Volumn 12, Issue 2, 1997, Pages 81-89

  Tome, M B ^a   Isaac, M T ^a,c   Harte, R ^a   Holland, C ^b  

^a Guy's Campus ^*  (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

5 HT1A receptor; Depression; Paroxetine; Pindolol; SSRI

Indexed keywords

PAROXETINE; PINDOLOL; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; AUTORADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG POTENTIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING;

EID: 0030816625     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199703000-00003     Document Type: Article

References (25)

1. Artigas F (1993) 5-HT and antidepressants: new views from microdialysis studies. Trends in Pharmacological Science, 14, 262.
2. Artigas F, Perez V and Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of General Psychiatry 51, 248-251.
3. Artigas F, Romero L, de Montigny C and Blier P (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neuroscience 19, 378-383.
4. Azmitia EC and Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphé nuclei in the rat. Journal of Comparative Neurology 179, 641-668.
5. Barden N, Reul JMHM and Holsboer F (1995) Do antidepressants stabilise mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends in Neuroscience 18, 6-10.
6. Beck AT, Ward CH, Mendelson M, Mock J and Erbaugh J (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
7. Bel N and Artigas F (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphé nuclei: an in vivo microdialysis study. European Journal of Pharmacology, 229, 101-103.
8. Berman RM, Darnell AM, Miller HL, Anand A and Charney DS (1997) Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind placebo-controlled trial. American Journal of Psychiatry, 154, 37-43.
9. Blier P, de Montigny C and Chaput Y ( 1990) Modifications of the serotonergic system by antidepressant treatments: implications for the therapeutic response in major depression. Journal of Clinical Psychopharmacology, 7, 24S-35S.
10. Blier P and de Montigny C (1994) Current advances and trends in the treatment of depression. Trends in Pharmacological Science, 15, 220-226.
11. Blier P and Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. Journal of Clinical Psychopharmacology, 15, 217-222.
12. Cowen PJ, Power AC, Ware CJ and Anderson IM (1994) 5-HTIA receptor subsensitivity in major depression. A neuroendocrine study with buspirone. British Journal of Psychiatry, 164, 372-379.
13. Goodrick PJ, Henry JH and Buki VMV (1995) Treatment of depression in patients with diabetes mellitus. Journal of Clinical Psychiatry, 56, 128-134.
14. Guy W (1976). ECDEU Assessment Manual For Psychopharmacology, revised edition. US Department of Health, Education, and Welfare, National Institute of Mental Health, Rockville, MD.
15. Hjorth S and Auerbach SB (1994) Further evidence for the importance of 5-HTIA autoreceptors in the action of selective serotonin reuptake inhibitors. European Journal of Pharmacology, 260, 251-255.
16. Hjorth S and Sharp T (1991) Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphé-innervated rat brain regions as measured by in vivo microdialysis. Life Science 48, 1779-1786.
17. Hoyer D and Schoeffer P (1991) 5-HT receptors; subtypes and second messengers. Journal of Receptor Research, 11, 197-214.
18. Invernizzi R, Carli M, DiClemente A and Samanin R (1991) Administration of 8-hydroxy-2-(di-n-propylamino) tetralin in raphé nuclei dorsalis and medialis reduces serotonin synthesis in rat brain: differences in potency and regional sensitivity. Journal of Neurochemistry, 56, 243-247.
19. Lesch KP, Poten B, Sohnle K and Schulte HM (1990) Pharmacology of the hypothermie response to 5-HT1A receptor activation in humans. European Journal of Clinical Pharmacology, 39, 17-19.
20. Middlemiss DN, Neil J and Tricklebank MD (1985) Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading induced by 8-OH-DPAT. British Journal of Pharmacology, 85, 251.
21. Montgomery SA and Asberg M (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389.
22. Paykel ES and Priest PG (1992) Recognition and management of depression in general practice; consensus statement. British Medical Journal, 305, 1198-1202.
23. Sinton CM and Fallon SL (1988) Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. European Journal of Pharmacology, 157, 173-181.
24. Stassen HH, Delini-Stula A and Angst J (1993) Time course of improvement under antidepressant treatment: a survival-analytical approach. European Neuropsychopharmacology, 3, 127-135.
25. Tome MB and Isaac MT (1996) Comparison of serotonin levels in depression treated by new and standard antidepressant regimes. European Psychiatry, 11 (Suppl 4), 294s.